Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

Condition:   Niemann-Pick Disease, Type C1 Intervention:   Drug: Hydroxypropyl-beta-cyclodextrin Sponsor:   CTD Holdings, Inc. Not yet recruiting - verified September 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials